Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$758M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$460M |
| 3 |
Adobe
ADBE
|
+$352M |
| 4 |
Intercontinental Exchange
ICE
|
+$327M |
| 5 |
Ferguson
FERG
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.47B |
| 2 |
Cisco
CSCO
|
+$1.1B |
| 3 |
NVIDIA
NVDA
|
+$1.01B |
| 4 |
Microsoft
MSFT
|
+$914M |
| 5 |
Apple
AAPL
|
+$753M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.36% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Trevi Therapeutics
TRVI
$2.53B
| $1.04M | ﹤0.01% |
166,076
+25,857
| +18% | +$123K |
|
|
PSTL
3027
Postal Realty Trust
PSTL
$701M
| $1.04M | ﹤0.01% |
72,782
+603
| +0.8% | +$8.1K |
|
3028
Bank7 Corp
BSVN
$495M
| $1.04M | ﹤0.01% |
26,800
-891
| -3% | -$37.2K |
|
3029
UroGen Pharma
URGN
$2.34B
| $1.03M | ﹤0.01% |
93,490
-507
| -0.5% | -$5.41K |
|
3030
Cullinan Oncology
CGEM
$1.26B
| $1.03M | ﹤0.01% |
136,414
-1,202
| -0.9% | -$11.5K |
|
3031
Real Brokerage
REAX
$523M
| $1.03M | ﹤0.01% |
254,242
+3,436
| +1% | +$16.3K |
|
3032
CSP Inc
CSPI
$84.2M
| $1.03M | ﹤0.01% |
67,166
-1,438
| -2% | -$24.6K |
|
3033
Townsquare Media
TSQ
$104M
| $1.03M | ﹤0.01% |
126,561
-5,149
| -4% | -$44.8K |
|
3034
LifeVantage
LFVN
$82.1M
| $1.03M | ﹤0.01% |
70,544
-3,639
| -5% | -$68.6K |
|
|
VERV
3035
DELISTED
Verve Therapeutics
VERV
| $1.03M | ﹤0.01% |
225,034
+4,532
| +2% | +$30.4K |
|
3036
Community Health Systems
CYH
$410M
| $1.03M | ﹤0.01% |
380,109
+2,949
| +0.8% | +$9.18K |
|
3037
Treace Medical Concepts
TMCI
$293M
| $1.03M | ﹤0.01% |
122,317
-3,628
| -3% | -$32.6K |
|
3038
iQIYI
IQ
$1.31B
| $1.02M | ﹤0.01% |
453,431
-15,762
| -3% | -$34.6K |
|
3039
OraSure Technologies
OSUR
$277M
| $1.02M | ﹤0.01% |
303,645
-2,730
| -0.9% | -$10.1K |
|
3040
Vanguard Communication Services ETF
VOX
$5.88B
| $1.02M | ﹤0.01% |
6,870
-2,135
| -24% | -$339K |
|
3041
Pacific Biosciences
PACB
$357M
| $1.02M | ﹤0.01% |
863,639
-4,340,328
| -83% | -$6.66M |
|
3042
Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF
EMCR
$61.1M
| $1.02M | ﹤0.01% |
34,488
+4,185
| +14% | +$124K |
|
3043
NetEase
NTES
$78.5B
| $1.02M | ﹤0.01% |
9,884
+153
| +2% | +$15.4K |
|
3044
indie Semiconductor
INDI
$875M
| $1.02M | ﹤0.01% |
498,931
+5,322
| +1% | +$18.5K |
|
3045
Cardiff Oncology
CRDF
$77.1M
| $1.02M | ﹤0.01% |
323,347
+34,732
| +12% | +$137K |
|
3046
STMicroelectronics
STM
$48.1B
| $1.01M | ﹤0.01% |
46,106
-111,761
| -71% | -$2.75M |
|
3047
Regenxbio
RGNX
$720M
| $1.01M | ﹤0.01% |
141,400
-19,736
| -12% | -$147K |
|
3048
Puma Biotechnology
PBYI
$450M
| $1.01M | ﹤0.01% |
340,886
+9,033
| +3% | +$28.3K |
|
3049
Navitas Semiconductor
NVTS
$3.57B
| $1.01M | ﹤0.01% |
490,362
-8,351
| -2% | -$23.9K |
|
|
CMU
3050
DELISTED
MFS High Yield Municipal Trust
CMU
| $1M | ﹤0.01% |
287,416
+70,000
| +32% | +$248K |
|
Similar funds
Bank of New York Mellon's Q1 2025 Portfolio in Review
As of Q1 2025, Bank of New York Mellon held 4,232 positions worth $505B, down 6.7% from $541B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of New York Mellon withdrew a net $15.2B in Q1 2025, closing 122 positions and reducing 2,490 holdings. Its most notable exit was Invesco S&P 500 Pure Value ETF, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in BNY Mellon Dynamic Value ETF worth $138M.
- Bank of New York Mellon's largest Q1 2025 buy was BNY Mellon Dynamic Value ETF: 5,452,259 shares worth $138M.
- Bank of New York Mellon added most to Johnson & Johnson in Q1 2025, an estimated $758M increase.
- Bank of New York Mellon's biggest Q1 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.47B.
- Bank of New York Mellon fully exited Invesco S&P 500 Pure Value ETF in Q1 2025, selling an estimated $123M.
- Bank of New York Mellon's ten largest holdings make up 23% of its $505B portfolio in Q1 2025.
- Bank of New York Mellon opened 116 new positions and closed 122 in Q1 2025.
- Bank of New York Mellon's portfolio value fell 6.7% quarter-over-quarter to $505B.
Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.